Advertisement

Long-Term Results of a German Prospective Multicenter Study on Colo-Rectal Cancer

  • Paul Hermanek
Conference paper

Abstract

Between 1984 and 1986 2347 patients with invasive colorectal carcinoma were registered in a prospective multicenter observation study in which seven German institutions participated. The 5-year survival following tumor resection primarily is influenced by the residual tumor (R) classification. Within the RO patients prognosis can be well estimated by pTNM and pTNM based stage grouping. Stage III is inhomogeneous and should be subdivided into pNl and pN2,3. The 5-year survival rates for the individual institutions showed significant differences for the total, but also for the individual stages. This reflects the importance of the surgeon as “prognostic factor”.

Key Words

Colorectal carcinoma Interdepartment variation Long-term prognosis pTNM Residual tumor (R) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hermanek P, Sobin LH (eds) (1992) UICC TNM classification of malignant tumours. 4th ed, 2nd revision 1992. Springer, Heidelberg Berlin New York Tokyo, pp 52–55Google Scholar
  2. 2.
    Heald RJ (1988) Holy place of rectal surgery. J Roy Soc Med 81: 503–508PubMedGoogle Scholar
  3. 3.
    Zirngibl H, Husemann B, Hermanek P (1990) Intra-operative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 33: 610–614PubMedCrossRefGoogle Scholar
  4. 4.
    Fielding LP, Arsenault PA, Chapuis PH, Dent 0, Gatright B, Hardcastle JD, Hermanek, P, Jass JR, Newland RC (1991) Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 6: 325–344PubMedCrossRefGoogle Scholar
  5. 5.
    Hermanek P (1991) Data collection aspects for the design of adjuvant treatment protocols in colorectal carcinoma. Onkologie 14: 491–497CrossRefGoogle Scholar
  6. 6.
    NIH (1990) Consensus conference adjuvant therapy for patients with colon and rectal carcinoma. JAMA 264: 1444–1450CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Paul Hermanek
    • 1
  1. 1.Department of SurgeryUniversity of ErlangenErlangenGermany

Personalised recommendations